Axillary surgery trial for breast cancer
ISRCTN | ISRCTN88463711 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN88463711 |
Secondary identifying numbers | SCTO30 |
- Submission date
- 19/08/2002
- Registration date
- 19/08/2002
- Last edited
- 07/04/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
- - -
Scientific
Scientific
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | Axillary surgery trial for breast cancer |
Study objectives | Not provided at time of registration |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Breast cancer |
Intervention | 1. Group A: Surgery, wide local excision and axillary node sampling, followed by radiotherapy to the breast and if the sample is positive, radiotherapy to the axillary lymph nodes 2. Group B: Surgery, wide local excision and axillary node clearance plus radiotherapy to the breast |
Intervention type | Procedure/Surgery |
Primary outcome measure | Not provided at time of registration |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/01/2003 |
Completion date | 01/01/2004 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Female |
Target number of participants | Not provided at time of registration |
Key inclusion criteria | 1. Histologically proven breast cancer 2. Tumour size no greater than 4 cm 3. No skin involvement 4. Aged less than 70 years 5. No medical contraindications to treatment protocols |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/01/2003 |
Date of final enrolment | 01/01/2004 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Sponsor information
UK Co-ordinating Committee for Cancer Research (UKCCCR)
Government
Government
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
https://ror.org/054225q67 |
Funders
Funder type
Not defined
Not provided at time of registration
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |